Akeso Biopharma logo

Akeso Biopharma

First in class and best in class therapeutic antibodies for patients worldwide. #9926.HK

105 employees · est. 2012 · China

VS
Innovent Biologics logo

Innovent Biologics

To develop and commercialize high-quality biopharmaceuticals that are affordable to ordinary people

846 employees · est. 2011 · Suzhou, China

Innovent Biologics is the older company (2012 vs 2011); Innovent Biologics is the larger of the two.

Side-by-Side Comparison

Akeso Biopharma Innovent Biologics
Founded
2012 2011 older
Headquarters
China Suzhou, China
Employees
105 846 larger
Industry
Biopharma, Biotechnology, Health Care Biopharma, Biotechnology, Manufacturing
Funding Stage
Series D Post Ipo Equity
Total Funding
$608.71M Not tracked yet
Funding Rounds
4 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Biopharmaceuticals, Monoclonal Antibodies, Biosimilars, Drug Development, Cancer Treatment, Metabolic Diseases, Autoimmune Diseases, Biologics Manufacturing, Clinical Trials, Commercialization, R&D, Global Standard Compliance, Funding, Strategic Partnerships, International Market Expansion
Website
akesobio.com innoventbio.com
Akeso Biopharma logo

About Akeso Biopharma

Akeso Biopharma, established in 2012, has positioned itself as a leading global biopharmaceutical organization with a focus on cancer, autoimmune diseases, inflammation, and cardiovascular conditions. The company has developed an extensive bio-pharmaceutical research, development, and industrializat...

Innovent Biologics logo

About Innovent Biologics

Innovent Biologics is a biopharmaceutical company established in 2011 with a commitment to develop and commercialize high-quality innovative medicines. The company focuses on treating major diseases such as cancer. It was publicly listed on the Main Board of the Stock Exchange of Hong Kong Limited w...

We will tell you when either one moves

BounceWatch watches Akeso Biopharma and Innovent Biologics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Akeso Biopharma and Innovent Biologics — by email.

Frequently Asked Questions

Akeso Biopharma — First in class and best in class therapeutic antibodies for patients worldwide. #9926.HK. Innovent Biologics — To develop and commercialize high-quality biopharmaceuticals that are affordable to ordinary people. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Akeso Biopharma has raised $608.71M while Innovent Biologics has raised undisclosed funding.
Akeso Biopharma and Innovent Biologics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Akeso Biopharma with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Akeso Biopharma on 12 Sep 2024, and Innovent Biologics on 20 Dec 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy